CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs

IntroductionSecondary and tertiary lymphoid structures are a critical target of suppression in many autoimmune disorders, protein replacement therapies, and in transplantation. Although antigen-specific regulatory T cells (Tregs), such as chimeric antigen receptor (CAR) Tregs, generally persist long...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Matteo Doglio, Jyoti Rana, Adriana Stucchi, Maite-Muñoz Melero, Alessia Ugolini, Tatiana Jofra, Cristiano Toma, Clara Bercher-Brayer, Pierluigi Carulli, Sandeep Kumar, Paolo Monti, Elisa Martini, Senthilkumar Thirumurugan, Moanaro Biswas, Chiara Bonini, Georgia Fousteri
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-07-01
Saila:	Frontiers in Immunology
Gaiak:	regulatory T cells (Tregs) C-X-C chemokine receptor type 5 (CXCR5) type 1 diabetes (T1D) pancreatic islet transplantation hemophilia chimeric antigen receptor (CAR)
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1513009/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!